Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Alpha Synuclein N-Terminal Acetylated Monomers

Human Recombinant N-Terminal Acetylated Alpha Synuclein Monomers (Type 1)

Product Specifications

Background

Alpha-Synuclein (SNCA) is expressed predominantly in the brain, where it is concentrated in presynaptic nerve terminals (1) . Alpha-synuclein is highly expressed in the mitochondria of the olfactory bulb, hippocampus, striatum and thalamus (2) . Functionally, it has been shown to significantly interact with tubulin (3), and may serve as a potential microtubule-associated protein. It has also been found to be essential for normal development of the cognitive functions; inactivation may lead to impaired spatial learning and working memory (4) . SNCA fibrillar aggregates represent the major non A-beta component of Alzheimers disease amyloid plaque, and a major component of Lewy body inclusions, and Parkinson's disease. Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha-synuclein and ubiquitin (5, 6) . Alpha synuclein purified from both normal and pathological brain tissue is N-acetylated (7) and this post-translational modification affects affect alpha-synuclein stability and toxicity (8) .

Product Name Alternative

N-acetylated Alpha synuclein monomer, N-terminal acetylated Alpha-synuclein monomer, Alpha synuclein protein monomer, Alpha synuclein monomer, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, Alpha synuclein monomers, SYN protein, Parkinson's disease familial 1 Protein, N‐terminal Ac‐αsyn

UNSPSC

12352202

UN Code

Non-hazardous

Hazard Statement

Non-hazardous

Gene ID

6622

Swiss Prot

P37840

Accession Number

NP_000336.1

Cellular Locus

Cytoplasm | Membrane | Nucleus

Expression System

E. coli

Host

E. coli

Origin Species

Human

Target

Alpha Synuclein N-Terminal Acetylated

Conjugation

No Tag

Nature

Recombinant

Applications

WB | SDS-PAGE | In vivo assay | In vitro assay

Field of Research

Neuroscience | Neurodegeneration | Alzheimer's Disease | Tangles & Tau | Neuroscience | Neurodegeneration | Parkinson's Disease | Synuclein | Neuroscience | Neurodegeneration | Multiple System Atrophy

Purification Method

Ion-exchange Purified

Purification

Ion-exchange Purified

Limit Of Detection

Acetylation cofirmed via ESI mass spectrometry. Low endotoxin <5 EU/mL @ 2mg/mL.

Concentration

2 mg/ml

Purity

>95%

Activity

Seeds aggregation of N-acetylated alpha synuclein monomer (SPR-331) in thioflavin T assay

Weight

0.05

Length

Full Length

Buffer

PBS pH 7.4

Molecular Weight

~14.46 kDa

Precautions

Not for use in humans. Not for use in diagnostics or therapeutics. For research use only.

Additionnal Information

For corresponding PFFs, see catalog# SPR-332

References & Citations

1. “Genetics Home Reference: SNCA”. US National Library of Medicine. (2013). 2. Zhang L., et al. (2008) Brain Res. 1244: 40-52. 3. Alim M.A., et al. (2002) J Biol Chem. 277(3): 2112-2117. 4. Kokhan V.S., Afanasyeva M.A., Van'kin G. (2012) Behav. Brain. Res. 231(1): 226-230. 5. Spillantini M.G., et al. (1997) Nature. 388(6645): 839-840. 6. Mezey E., et al. (1998) Nat Med. 4(7): 755-757. 7. Anderson, J.P. et al. (2006) J Biol Chem. 2006;281:29739–29752. 8. Vinueza-Gavilanes, R. et al. (2020) Neurobiol Dis. 137, 2020, Article 104783

Shipping Conditions

Dry Ice. Shipping note: Product will be shipped separately from other products purchased in the same order.

Storage Conditions

-80ºC

Notes

For corresponding PFFs, see catalog# SPR-332

Protein Length

Full Length

Background Reference 01

1. “Genetics Home Reference: SNCA”. US National Library of Medicine. (2013) . 2. Zhang L., et al. (2008) Brain Res. 1244: 40-52. 3. Alim M.A., et al. (2002) J Biol Chem. 277 (3) : 2112-2117. 4. Kokhan V.S., Afanasyeva M.A., Van'kin G. (2012) Behav. Brain. Res. 231 (1) : 226-230. 5. Spillantini M.G., et al. (1997) Nature. 388 (6645) : 839-840. 6. Mezey E., et al. (1998) Nat Med. 4 (7) : 755-757. 7. Anderson, J.P. et al. (2006) J Biol Chem. 2006;281:29739–29752. 8. Vinueza-Gavilanes, R. et al. (2020) Neurobiol Dis. 137, 2020, Article 104783

Location

Cytoplasm | Membrane | Nucleus

Immunogen Species

Human

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human sRANK Receptor Construction Kit
RHF909CK 960 Tests

Human sRANK Receptor Construction Kit

Sign In for Pricing
View Details
Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)
MBS1296265-01 0.02 mg (E-Coli)

Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)

Sign In for Pricing
View Details
Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)
MBS1296265-02 0.1 mg (E-Coli)

Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)

Sign In for Pricing
View Details
Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)
MBS1296265-03 0.02 mg (Yeast)

Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)

Sign In for Pricing
View Details
Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)
MBS1296265-04 0.1 mg (Yeast)

Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)

Sign In for Pricing
View Details
Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)
MBS1296265-05 0.02 mg (Baculovirus)

Recombinant Pseudomonas fluorescens Poly (3-hydroxyoctanoate) depolymerase (phaZ)

Sign In for Pricing
View Details